FDAHealthJune 10, 2025
Boston Scientific Corporation — VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.
⚠️ Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- June 10, 2025
Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.
What's affected?
- Product
- VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.
- Lot code
- 35935598
Additional details
UDI-DI 00685447006121 Lot 35935598
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 14,724.
Get Health recall alerts
Delivered to your inbox. Free. No account required.